2021 annual financial data
Inovio Pharmaceuticals 2021 Operating margin
Direct answer
Operating margin was -16,972.34%.
Operating income was -301,217,919 USD and net income was -303,658,710 USD.
Operating cash flow was -215,708,525 USD.
Get free Inovio Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,774,758 USD
- Operating income
- -301,217,919 USD
- Net income
- -303,658,710 USD
- Operating cash flow
- -215,708,525 USD